美国共病物质使用障碍与精神疾病成人治疗模式及就医障碍
该研究基于2021—2023年美国全国药物使用与健康调查横断面数据,分析共病物质使用障碍(SUD)与精神疾病成人接受两种治疗的比例及障碍。结果显示两种治疗同时覆盖率从2021年7.5%升至2023年18.2%(任何精神疾病组),严重精神疾病组从12.3%升至25.6%,但总体仍低,未治疗者中不足2%认为需要并寻求治疗。
要点
- 共病SUD与任何精神疾病成人同时接受两种治疗的比例2023年仅18.2%。
- 共病SUD与严重精神疾病成人同时治疗比例2023年为25.6%。
- 未治疗者中不足2%认为需要并寻求治疗,常见障碍包括不重视、污名、费用和可及性。
核心结论
- 尽管新冠后略有上升,美国共病SUD与精神疾病成人同时接受两种治疗的比例仍低,差异持续存在。
研究设计与样本
- 分析2021—2023年全国药物使用与健康调查横断面数据,纳入过去一年符合SUD且任何精神疾病或严重精神疾病标准的18岁及以上成人。
- 采用加权患病率估计和多变量logistic回归模型分析同时接受两种治疗及相关因素。
主要发现
- 共病SUD与任何精神疾病成人同时接受两种治疗的比例从2021年7.5%升至2022年16.9%和2023年18.2%。
- 共病SUD与严重精神疾病成人同时接受两种治疗的比例从2021年12.3%升至2022年25.0%和2023年25.6%。
- 女性、年龄较大和自评健康较差与同时接受两种治疗的较高 odds 相关,非白人和无保险成人 odds 显著较低。
- 未治疗成人中不足2%报告认为需要并寻求治疗,常见障碍包括治疗非优先、污名、费用、可及性有限和缺乏准备。
临床怎么用
- 临床应主动筛查共病SUD与精神疾病患者的治疗需求,不能仅依赖患者主动求助。
- 针对未治疗者常见的障碍(不重视、污名、费用、可及性),需加强外展、减少污名并改善服务协调。
- 关注非白人和无保险成人的治疗差异,推动 parity 执行和稳定融资。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to examine treatment patterns among U.S. adults with co-occurring substance use disorder (SUD) and mental illness, identify sociodemographic factors associated with receipt of treatment for both conditions, and characterize barriers to care. METHODS: The authors analyzed cross-sectional data from the 2021-2023 National Survey on Drug Use and Health. Adults age 18 years and older who met criteria for past-year SUD and either any mental illness or serious mental illness were included. The primary outcome was receipt of treatment for both conditions in the past year, and secondary outcomes included self-reported barriers to treatment. Weighted prevalence estimates and multivariable logistic regression models were used. RESULTS: Among adults with co-occurring SUD and any mental illness, receipt of treatment for both increased from 7.5% in 2021 to 16.9% in 2022 and 18.2% in 2023. Among adults with co-occurring SUD and serious mental illness, receipt of treatment for both increased from 12.3% in 2021 to 25.0% in 2022 and 25.6% in 2023. Female sex, older age, and poorer self-rated health were associated with higher odds of receiving treatment for both conditions. Non-White and uninsured adults had significantly lower odds. Less than 2% of untreated adults reported perceiving a need for and seeking treatment. Commonly reported barriers included treatment not being a priority, stigma, cost, limited access, and lack of readiness. CONCLUSIONS: Receipt of both substance use treatment and mental health treatment remained low among U.S. adults with co-occurring disorders despite modest post-COVID-19 pandemic increases. Persistent disparities and barriers suggest a need for stronger parity enforcement, stable financing, and improved coordination across behavioral health services.
引用
- Lin Y, Li H, Nahata MC, et al. Treatment Patterns and Barriers to Care Among U.S. Adults With Co-Occurring Substance Use Disorder and Mental Illness. Am J Psychiatry. 2026. PMID: 42415254. doi:10.1176/appi.ajp.20251314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。